<DOC>
	<DOCNO>NCT00239798</DOCNO>
	<brief_summary>This study evaluate safety efficacy FTY720 combine cyclosporine corticosteroid patient receive kidney transplant .</brief_summary>
	<brief_title>Efficacy Safety FTY720 de Novo Adult Renal Transplant Recipients</brief_title>
	<detailed_description />
	<mesh_term>Fingolimod Hydrochloride</mesh_term>
	<criteria>Inclusion Criteria Patients complete 12 Month visit Core trial either study drug . Female capable become pregnant require medically approve method birth control 3 Month study medication stop . Exclusion Criteria None</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Transplantation , kidney , organ transplant</keyword>
</DOC>